03/04/2021
4:10 PM | G1 Therapeutics (Issuer)
Malik Rajesh (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2021
3:54 PM | G1 Therapeutics (Issuer)
Moses Jennifer K. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2021
4:16 PM | G1 Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/18/2021
4:49 PM | G1 Therapeutics (Issuer)
Velleca Mark A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2021
5:34 AM | G1 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/11/2021
12:07 PM | G1 Therapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G
| |
02/08/2021
9:23 AM | FMR LLC (Filed by)
G1 Therapeutics (Subject)
| Form SC 13G/A
| |
02/03/2021
12:33 PM | G1 Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A
| |
01/29/2021
3:07 PM | G1 Therapeutics (Issuer)
Malik Rajesh (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2021
8:57 AM | BlackRock Inc. (Filed by)
G1 Therapeutics (Subject)
| Form SC 13G/A
| |
|
01/22/2021
5:47 PM | G1 Therapeutics (Issuer)
Malik Rajesh (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/21/2021
4:31 PM | G1 Therapeutics (Issuer)
Velleca Mark A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/11/2021
5:02 AM | G1 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/05/2021
5:25 PM | G1 Therapeutics (Issuer)
G1 Therapeutics (Issuer)
Moses Jennifer K. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2021
5:22 PM | G1 Therapeutics (Issuer)
G1 Therapeutics (Issuer)
Gupta Soma (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2021
5:18 PM | G1 Therapeutics (Issuer)
Hanson James S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2021
5:14 PM | G1 Therapeutics (Issuer)
Malik Rajesh (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2021
5:12 PM | G1 Therapeutics (Issuer)
MURDOCK TERRY L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2021
5:10 PM | Avagliano Mark (Reporting)
G1 Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2020
3:50 PM | G1 Therapeutics (Issuer)
RUDNICK SETH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2020
5:54 PM | G1 Therapeutics (Issuer)
RUDNICK SETH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2020
5:01 PM | G1 Therapeutics (Issuer)
Velleca Mark A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2020
3:50 PM | G1 Therapeutics (Issuer)
Malik Rajesh (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2020
4:30 PM | G1 Therapeutics (Issuer)
RUDNICK SETH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2020
3:20 PM | G1 Therapeutics (Issuer)
RUDNICK SETH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2020
3:54 PM | G1 Therapeutics (Issuer)
MUIR GLENN P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2020
3:33 PM | Bailey John E. Jr. (0001806147) (Reporting)
G1 Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/10/2020
9:27 AM | FMR LLC (Filed by)
G1 Therapeutics (Subject)
| Form SC 13G/A
| |
11/04/2020
4:15 PM | G1 Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/04/2020
3:05 PM | G1 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/30/2020
3:08 PM | G1 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/09/2020
8:10 AM | G1 Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A
| |
09/08/2020
7:38 PM | G1 Therapeutics (Issuer)
Hanson James S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/30/2020
3:17 PM | G1 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/12/2020
3:42 PM | G1 Therapeutics (Issuer)
Schwalm Cynthia (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2020
3:40 PM | G1 Therapeutics (Issuer)
RUDNICK SETH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2020
3:39 PM | G1 Therapeutics (Issuer)
MUIR GLENN P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2020
3:38 PM | G1 Therapeutics (Issuer)
Nicholson Garry A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2020
3:37 PM | Deese Willie A (Reporting)
G1 Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2020
3:34 PM | Bailey John E. Jr. (0001806147) (Reporting)
G1 Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2020
3:32 PM | ESHELMAN FREDRIC N (Reporting)
G1 Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2020
5:08 AM | G1 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/06/2020
4:16 PM | G1 Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/06/2020
3:05 PM | G1 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2020
3:53 PM | G1 Therapeutics (Issuer)
Gupta Soma (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2020
3:52 PM | G1 Therapeutics (Issuer)
Gupta Soma (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/16/2020
6:00 AM | G1 Therapeutics (Issuer)
Moses Jennifer K. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/16/2020
6:00 AM | G1 Therapeutics (Issuer)
Malik Rajesh (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/16/2020
6:00 AM | G1 Therapeutics (Issuer)
Velleca Mark A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/11/2020
3:44 PM | G1 Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G
| |
02/11/2020
3:20 PM | G1 Therapeutics (Subject)
Hatteras Venture Partners IV SBIC, LP (Filed by)
| Form SC 13G/A
| |
02/03/2020
4:21 PM | G1 Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/28/2020
10:49 AM | G1 Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A
| |
01/24/2020
3:59 PM | G1 Therapeutics (Issuer)
Velleca Mark A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2020
3:58 PM | G1 Therapeutics (Issuer)
Moses Jennifer K. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2020
3:58 PM | G1 Therapeutics (Issuer)
Malik Rajesh (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2020
5:12 AM | G1 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/23/2019
3:31 PM | G1 Therapeutics (Filer)
| Form 8-K/A
| |
11/05/2019
4:16 PM | G1 Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/05/2019
3:07 PM | G1 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/01/2019
4:29 PM | G1 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/12/2019
8:56 PM | G1 Therapeutics (Subject)
Lumira Capital Investment Management Inc. (Filed by)
| Form SC 13G/A
| |
08/07/2019
4:16 PM | G1 Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/30/2019
3:29 PM | Avagliano Mark (Reporting)
G1 Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/30/2019
3:28 PM | Avagliano Mark (Reporting)
G1 Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/19/2019
8:58 PM | G1 Therapeutics (Issuer)
Moses Jennifer K. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2019
5:05 AM | G1 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2019
3:38 PM | ESHELMAN FREDRIC N (Reporting)
G1 Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2019
3:36 PM | G1 Therapeutics (Issuer)
RUDNICK SETH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2019
3:35 PM | Deese Willie A (Reporting)
G1 Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2019
3:33 PM | G1 Therapeutics (Issuer)
Nicholson Garry A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2019
3:32 PM | G1 Therapeutics (Issuer)
MUIR GLENN P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2019
3:31 PM | G1 Therapeutics (Issuer)
Schwalm Cynthia (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2019
3:30 PM | G1 Therapeutics (Issuer)
WITTY ANDREW (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2019
3:26 PM | G1 Therapeutics (Issuer)
Moses Jennifer K. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2019
4:16 PM | G1 Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2019
3:26 PM | G1 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/30/2019
3:10 PM | G1 Therapeutics (Filer)
| Form DEFA14A
| |
04/30/2019
3:05 PM | G1 Therapeutics (Filer)
| Form DEF 14A
| |
04/29/2019
3:07 PM | G1 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/26/2019
3:34 PM | G1 Therapeutics (Filer)
| Form 10-K/A
| |
02/28/2019
3:08 PM | G1 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2019
3:51 PM | G1 Therapeutics (Subject)
Hatteras Venture Partners IV SBIC, LP (Filed by)
| Form SC 13G/A
| |
01/28/2019
8:10 PM | G1 Therapeutics (Issuer)
Malik Rajesh (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/28/2019
11:13 AM | FRANKLIN RESOURCES INC (Filed by)
G1 Therapeutics (Subject)
| Form SC 13G/A
| |
01/17/2019
4:52 PM | G1 Therapeutics (Issuer)
Moses Jennifer K. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2019
4:52 PM | G1 Therapeutics (Issuer)
Velleca Mark A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2019
8:37 AM | G1 Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G
| |
01/02/2019
4:46 PM | G1 Therapeutics (Issuer)
Strum Jay (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2019
4:32 PM | G1 Therapeutics (Issuer)
Moses Jennifer K. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2019
4:29 PM | G1 Therapeutics (Issuer)
Hanson James S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2019
4:29 PM | G1 Therapeutics (Issuer)
PHILLIPS BARCLAY A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2019
4:29 PM | G1 Therapeutics (Issuer)
MURDOCK TERRY L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2019
4:29 PM | G1 Therapeutics (Issuer)
Malik Rajesh (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2019
4:28 PM | DEMAREE JOHN (Reporting)
G1 Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2019
4:28 PM | G1 Therapeutics (Issuer)
Velleca Mark A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2018
3:59 PM | G1 Therapeutics (Issuer)
Hanson James S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2018
3:59 PM | G1 Therapeutics (Issuer)
Schwalm Cynthia (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2018
4:24 PM | G1 Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/17/2018
3:27 PM | G1 Therapeutics (Issuer)
Malik Rajesh (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
